Interestingly, frequencies and absolute number of Il1rl1+ Tregs were decreased in the BC281-treated group vs BC462 control in the MLL-AF9 leukemia model (Fig. 6F, Supplementary Fig. 22C). This evidence concerns the gene KMT2A and leukemia.